[1. R. Ng, N. Better and M. Green, Anticancer agents and cardiotoxicity, Semin. Oncol. 33 (2006) 2-14; DOI: 10.1053/j.seminoncol.2005.11.001.10.1053/j.seminoncol.2005.11.001]Search in Google Scholar
[2. K. Schimmel, D. Richel, R. van den Brink and H. J. Guchelaar, Cardiotoxicity of cytotoxic drugs, Cancer Treat. Rev. 30 (2004) 181-191; DOI: 10.1016/j.ctrv.2003.07.003.10.1016/j.ctrv.2003.07.003]Search in Google Scholar
[3. T. Simunek, M. Sterba, O. Popelova, M. Adamcová, R. Hrdina and V. Gersl, Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron, Pharmacol. Rep. 61 (2009) 154-171.]Search in Google Scholar
[4. S. Kalender, Y. Kalender, A. Ates, M. Yel, E. Olcay and S. Candan, Protective role of antioxidant vitamin E and catechin on idarubicin-induced cardiotoxicity in rats, Braz. J. Med. Biol. Res. 35 (2002) 1379-1387; DOI: 10.1590/s0100-879x2002001100017.10.1590/S0100-879X2002001100017]Search in Google Scholar
[5. Y. Kalender, M. Yel and S. Kalender, Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats - the effects of vitamin E and catechin, Toxicology 209 (2005) 39-45; DOI: 10.1016/j.tox.2004.12.003.10.1016/j.tox.2004.12.003]Search in Google Scholar
[6. J. H. Doroshow, Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents, Biochem. Biophys. Res. Commun. 135 (1986) 330-335; DOI: 10.1016/0006-291x(86)90981-2.10.1016/0006-291X(86)90981-2]Search in Google Scholar
[7. B. K. Sinha, A. G. Katki, G. Batist, K. H. Cowan and C. E. Myers, Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells, Biochem. Pharmacol. 36 (1987) 793-796; DOI: 10.1016/0006-2952(87)90164-x.10.1016/0006-2952(87)90164-X]Search in Google Scholar
[8. A. L. A. Ferreira, L. S. Matsubara andB. B. Matsubara, Anthracycline-induced cardiotoxicity, Cardiovasc. Hematol. Agents Med. Chem. 6 (2008) 278-281; DOI: 10.2174/187152508785909474.10.2174/18715250878590947418855640]Search in Google Scholar
[9. C. Carvalho, R. X. Santos, S. Cardoso, S. Correia, P. J. Oliveira, M. S. Santos and P. I. Moreira, Doxorubicin: the good, the bad and the ugly effect, Curr. Med. Chem. 16 (2009) 3267-3285; DOI: 10.2174/092986709788803312.10.2174/09298670978880331219548866]Search in Google Scholar
[10. Y. Chen, P. Jungsuwadee, M. Vore, D. A. Butterfield and D. K. St Clair, Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues, Mol. Interv. 7 (2007) 147-156; DOI: 10.1124/mi.7.3.6.10.1124/mi.7.3.617609521]Search in Google Scholar
[11. A. Mohan, S. Narayanan, S. Sethuraman and U. M. Krishnan, Combinations of plant polyphenols & anti-cancer molecules: a novel treatment strategy for cancer chemotherapy, Anti-Cancer Agents Med. Chem. 13 (2013) 281-295; DOI: 10.2174/1871520611313020015.10.2174/187152061131302001522721388]Search in Google Scholar
[12. V. Hanušová, I. Boušová and L. Skálová, Possibilities to increase the effectiveness of doxorubicin in cancer cells killing, Drug Metab. Rev. 43 (2011) 540-557; DOI: 10.3109/03602532.2011. 609174.]Search in Google Scholar
[13. H. K. Biesalski and J. Frank, Antioxidants in cancer therapy: is there a rationale to recommend antioxidants during cancer therapy? Biofactors 17 (2003) 229-240; DOI: 10.1002/biof.5520170122.10.1002/biof.552017012212897444]Search in Google Scholar
[14. K. A. Conklin, Cancer chemotherapy and antioxidants, J. Nutr. 134 (2004) 3201S-3204S.]Search in Google Scholar
[15. D. Procházková, I. Boušová and N. Wilhelmová, Antioxidant and prooxidant properties of flavonoids, Fitoterapia 82 (2011) 513-523; DOI: 10.1016/j.fitote.2011.01.018.10.1016/j.fitote.2011.01.01821277359]Search in Google Scholar
[16. L. Patil and R. Balaraman, Effect of green tea extract on doxorubicin induced cardiovascular abnormalities: antioxidant action, Iran. J. Pharm. Res. 10 (2011) 89-96.]Search in Google Scholar
[17. Y. Du and H. X. Lou, Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin- -induced toxicity in cardiomyocytes, Eur. J. Pharmacol. 591 (2008) 96-101; DOI: 10.1016/j.ejphar. 2008.06.068.]Search in Google Scholar
[18. J. Zheng, H. C. M. Lee, M. M. bin Sattar, Y. Huang and J. S. Bian, Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury, Eur. J. Pharmacol. 652 (2011) 82-88; DOI: 10.1016/j.ejphar.2010.10.082.10.1016/j.ejphar.2010.10.08221114975]Search in Google Scholar
[19. R. H. Mohamed, R. A. Karam and M. G. Amer, Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-alpha, iNOS and NF-kappa B, Brain Res. Bull. 86 (2011) 22-28; DOI: 10.1016/j.brainresbull.2011.07.001.10.1016/j.brainresbull.2011.07.00121763406]Search in Google Scholar
[20. K. Sato, K. Sueoka, R. Tanigaki, H. Tajima, A. Nakabayashi, Y. Yoshimura and Y. Hosoim, Green tea extracts attenuate doxorubicin-induced spermatogenic disorders in conjunction with higher telomerase activity in mice, J. Assist. Reprod. Genet. 27 (2010) 501-508; DOI: 10.1007/s10815-010- -9438-z.]Search in Google Scholar
[21. N. Kassner, K. Huse, H. J. Martin, U. Gödtel-Armbrust, A. Metzger, I. Meineke, J. Brockmöller, K. Klein, U. M. Zanger, E. Maser and L. Wojnowski, Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver, Drug Metab. Dispos. 36 (2008) 2113-2120; DOI: 10.1124/dmd.108.022251.10.1124/dmd.108.02225118635746]Search in Google Scholar
[22. W. X. Huang, L. Y. Ding, Q. A. Huang, H. Hu, S. Liu, X. Yang, X. Hu, Y. Dang, S. Shen, J. Li, X. Ji, S. Jiang, J. O. Liu and L. Yu, Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma, Hepatology 52 (2010) 703-714; DOI: 10.1002/hep.23723.10.1002/hep.2372320683966]Search in Google Scholar
[23. M. N. Berry, A. Edwards and G. Barritt, Isolated Hepatocytes: Preparation, Properties and Applications, Elsevier Science Publishers, Amsterdam 1991, pp. 15-58.]Search in Google Scholar
[24. H. Wang and J. A. Joseph, Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader, Free Rad. Biol. Med. 27 (1999) 612-616; DOI: 10.1016/s0891-5849(99) 00107-0.]Search in Google Scholar
[25. N. P. Seeram, Y. J. Zhang and M. G. Nair, Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins, Nutr. Cancer 46 (2003) 101-106; DOI: 10.1207/s15327914nc4601_13.10.1207/S15327914NC4601_1312925310]Search in Google Scholar
[26. G. Liang, A. Z. Tang, X. Z. Lin, L. Li, S. Zhang, Z. Huang, H. Tang and Q. Q. Li, Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer, Int. J. Oncol. 37 (2010) 111-123; DOI: 10.3892/ijo_00000659.10.3892/ijo_00000659]Search in Google Scholar
[27. G. W. Dryden, A. Lam, K. Beatty, H. H. Qazzaz and C. J. McClain, A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis, Inflamm. Bowel Dis. 19 (2013) 1904-1912; DOI: 10.1097/MIB.0b013e31828f5198.10.1097/MIB.0b013e31828f519823846486]Search in Google Scholar
[28. H. H. Chow, I. A. Hakim, D. R. Vining, J. A. Crowell, J. Ranger-Moore, W. M. Chew, C. A. Celaya, S. R. Rodney, Y. Hara and D. S. Alberts, Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals, Clin. Cancer Res. 11 (2005) 4627-4633; DOI: 10.1158/1078-0432.CCR-04-2549.10.1158/1078-0432.CCR-04-254915958649]Search in Google Scholar
[29. G. Stammler and M. Volm, Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines, Anti-cancer Drugs 8 (1997) 265-268.10.1097/00001813-199703000-000079095331]Search in Google Scholar
[30. G. Mazzanti, F. Menniti-Ippolito, P. A. Moro, F. Cassetti, R. Raschetti, C. Santuccio and S. Mastrangelo, Hepatotoxicity from green tea: a review of the literature and two unpublished cases, Eur. J. Clin. Pharmacol. 65 (2009) 331-341; DOI: 10.1007/s00228-008-0610-7 10.1007/s00228-008-0610-719198822]Search in Google Scholar